Craniofacial Fibrous Dysplasia: Surgical Management and Long-Term Outcomes at a Referral Center in Mexico City

Abstract

Background Craniofacial fibrous dysplasia (CFD) is an uncommon benign condition in which a bone is replaced by fibrous tissue. An adequate clinical characterization considering the number of affected bones and functional impairment is important to determine the most effective surgical intervention for its management. This study aims to present our institution's experience in the evaluation and management of CFD.

Methods This was a retrospective study that included patients with CFD managed at our institution. Data included demographic characteristics, afflicted bones, surgical procedures performed, and recurrence. Results are presented as mean and percentages. Recurrence-free years and association between the type of surgery and recurrence was evaluated.

Results Eighteen patients were included (11 females, 61%). The zygomatic, maxillary, and frontal bones were the most commonly affected with eight (18%) cases each. The most common procedure was bone burring, with 36 procedures. Recurrence was more prevalent after burring (58.3%) and occurred earlier than in the bone resection group (13 vs. 15 years, p > 0.05).

Conclusion Surgery continues to be the cornerstone of CFD treatment. Bone burring is effective for debulking and contouring but increases the risk for recurrence. An individualized approach should be tailored according to the anatomical location of the disease, type of CFD, behavior of the lesion, and accompanying clinical complaints.

Keywords

fibrous dysplasia - polyostotic - craniofacial fibrous dysplasia - mandibular osteotomy - follow-up studies - recurrence - GTP-binding proteins

Ethical Statement

This study was approved by our institutional ethics committee.

Publikationsverlauf

Artikel online veröffentlicht:
13. März 2023

• References

• 1 Ricalde P, Magliocca KR, Lee JS. Craniofacial fibrous dysplasia. Oral Maxillofac Surg Clin North Am 2012; 24 (03) 427-441
• 2 Lichtenstein L. Polyostotic fibrous dysplasia. Arch Surg 1938; 36 (05) 874-898
• 3 Weinstein LS, Chen M, Liu J. Gs(alpha) mutations and imprinting defects in human disease. Ann N Y Acad Sci 2002; 968: 173-197
• 4 Florez H, Peris P, Guañabens N. Fibrous dysplasia. Clinical review and therapeutic management. Med Clin (Barc) 2016; 147 (12) 547-553
• 5 Shenker A, Weinstein LS, Sweet DE, Spiegel AM. An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. J Clin Endocrinol Metab 1994; 79 (03) 750-755
• 6 Lloyd T, Berridge NL. Fibrous dysplasia. In: Brennan PA, Schliephake H, Ghali GE, Cascarini L. Maxillofacial Surgery, 3rd ed, Churchill Livingstone; 2017: 1358-1367
• 7 Katz BJ, Nerad JA. Ophthalmic manifestations of fibrous dysplasia: a disease of children and adults. Ophthalmology 1998; 105 (12) 2207-2215
• 8 Burke AB, Collins MT, Boyce AM. Fibrous dysplasia of bone: craniofacial and dental implications. Oral Dis 2017; 23 (06) 697-708
• 9 Boyce AM, Burke A, Cutler Peck C, DuFresne CR, Lee JS, Collins MT. Surgical management of polyostotic craniofacial fibrous dysplasia: long-term outcomes and predictors for postoperative regrowth. Plast Reconstr Surg 2016; 137 (06) 1833-1839
• 10 Rahman AM, Madge SN, Billing K. et al. Craniofacial fibrous dysplasia: clinical characteristics and long-term outcomes. Eye (Lond) 2009; 23 (12) 2175-2181
• 11 Wu H, Yang L, Li S. et al. Clinical characteristics of craniomaxillofacial fibrous dysplasia. J Craniomaxillofac Surg 2014; 42 (07) 1450-1455
• 12 Yang L, Wu H, Lu J, Teng L. Prevalence of different forms and involved bones of craniofacial fibrous dysplasia. J Craniofac Surg 2017; 28 (01) 21-25
• 13 Lee JS, FitzGibbon EJ, Chen YR. et al. Clinical guidelines for the management of craniofacial fibrous dysplasia. Orphanet J Rare Dis 2012; 7 (Suppl. 01) S2
• 14 Javaid MK, Boyce A, Appelman-Dijkstra N. et al. Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium. Orphanet J Rare Dis 2019; 14 (01) 139
• 15 Gabbay JS, Yuan JT, Andrews BT, Kawamoto HK, Bradley JP. Fibrous dysplasia of the zygomaticomaxillary region: outcomes of surgical intervention. Plast Reconstr Surg 2013; 131 (06) 1329-1338
• 16 Valentini V, Cassoni A, Marianetti TM, Terenzi V, Fadda MT, Iannetti G. Craniomaxillofacial fibrous dysplasia: conservative treatment or radical surgery? A retrospective study on 68 patients. Plast Reconstr Surg 2009; 123 (02) 653-660
• 17 Denadai R, Raposo-Amaral CA, Raposo-Amaral CE. Fat grafting in managing craniofacial deformities. Plast Reconstr Surg 2019; 143 (05) 1447-1455
• 18 Yeow VK, Chen YR. Orthognathic surgery in craniomaxillofacial fibrous dysplasia. J Craniofac Surg 1999; 10 (02) 155-159
• 19 Florenzano P, Pan KS, Brown SM. et al. Age-related changes and effects of bisphosphonates on bone turnover and disease progression in fibrous dysplasia of bone. J Bone Miner Res 2019; 34 (04) 653-660